• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Setrusumab Antibody – Human Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5822826

Setrusumab (BPS 804) is a fully humanized monoclonal antibody targeting sclerostin, effectively enhancing bone strength. It is utilized in research on Osteogenesis Imperfecta (OI) and cancer. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Setrusumab, Monoclonal Antibody
Full Product Name
Setrusumab
Product Synonym Names
BPS 804
Clonality
Monoclonal
Host
Human
Species Reactivity
Sclerostin
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
1847394-95-9
In_vitro
Setrusumab, administered at a dosage of 100 mg/kg via intravenous injection once weekly for a duration of four weeks, inhibited bone metastasis and muscle weakness induced by breast cancer in mice [1].

Other Notes

Small volumes of anti-Setrusumab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Setrusumab purchase

MBS5822826 is an antibody targeting Setrusumab. Reactive in Sclerostin. Host: Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000